Antitrust in Healthcare
Lina discusses the dual approach to antitrust enforcement, highlighting the reactive nature of merger reviews and the proactive scrutiny of monopolistic practices. She emphasizes the focus on healthcare, detailing recent successes in challenging big pharma's patenting strategies, which have led to significant price reductions for essential medications like asthma inhalers. The conversation underscores the impact of blocking certain mergers on innovation and patient access to vital treatments.In this clip
From this podcast
Prof G Markets
Unlocking Innovation Through Antitrust Enforcement — ft. Lina Khan | Prof G Markets
Related Questions